Previous studies identified miR-21-3p target genes: in ovarian cells it targets NAV3 [73], a known tumor suppressor; in hepatocellular carcinoma, it targets SMAD7, an inhibitor of the TGFβ pathway [74]; and in ESCC, it targets TRAF4 [58]. This evidence concerns the gene NAV3 and hepatocellular carcinoma.